Sponsored by:

Molecular Imaging: Page 453

Chalk River shutdown hurts Draxis' results
By AuntMinnie.com staff writers
Lower product sales in its radiopharmaceutical business combined with the stronger Canadian dollar to depress revenues at Canadian radiopharmaceutical developer Draxis Health of Montreal in 2007.
February 7, 2008
NRC investigates Covidien production issue
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) said it is working with Mallinckrodt, a division of Covidien of Hamilton, Bermuda, to investigate elevated levels of molybdenum-99 in the company's technetium-99m isotope.
February 7, 2008
Medical sales drive Covidien's Q1 growth
By AuntMinnie.com staff writers
Double-digit sales growth in its medical devices and imaging divisions helped contribute to increased first-quarter revenue for Covidien of Hamilton, Bermuda.
February 6, 2008
Digirad revenues edge up, loss narrows
By AuntMinnie.com staff writers
Nuclear medicine firm Digirad of Poway, CA, turned in stronger financial results based on higher annual revenues and decreased operating expenses for 2007.
February 6, 2008
NuView, Thomas Jefferson to collaborate
By AuntMinnie.com staff writers
NuView Radiopharmaceuticals of Park City, UT, has entered an agreement with Thomas Jefferson University to distribute and commercialize a tumor-specific imaging agent used in the diagnosis of breast and prostate tumors.
February 5, 2008
Carestream launches multispectral imaging system
By AuntMinnie.com staff writers
Carestream Molecular Imaging, a division of Rochester, NY-based Carestream Health, has launched a new digital system for fluorescent multispectral optical molecular imaging.
February 5, 2008
Naviscan promotes Mirabella
By AuntMinnie.com staff writers
PET developer Naviscan PET Systems has named president and CEO Paul Mirabella as chairman.
February 4, 2008
PharmaLogic P.E.T. Services receives PET nod
By AuntMinnie.com staff writers
PharmaLogic P.E.T. Services of Montreal has received approval from the Canadian government to begin selling its formulation of FDG.
February 3, 2008
SUVs need adjusting for high-resolution PET/CT
By Wayne Forrest
Radiologists and clinicians working with high-resolution PET/CT should adjust standardized uptake values (SUVs) accordingly to reduce the chance of errors in classifying head and neck tumors, according to researchers from the University of Minnesota in Minneapolis. In a recent study, the team found that maximum SUVs for head and neck lesions are significantly higher with high-resolution PET/CT than with conventional or lower-resolution systems.
January 31, 2008
BMS posts last financials for medical imaging business
By AuntMinnie.com staff writers
Pharmaceutical developer Bristol-Myers Squibb (BMS) has posted its 2007 fourth-quarter and year-end financial results, including results for the medical imaging division that it sold to venture capital firm Avista Capital Partners last month.
January 30, 2008
PET/CT shows value in head and neck tumors
By Brian Casey
January 30, 2008
GE partners with German firm on cancer therapeutics
By AuntMinnie.com staff writers
Multimodality vendor GE Healthcare of Chalfont St. Giles, U.K., has expanded a partnership with a German firm to include collaboration in the field of molecular imaging and its application to the development of cancer therapeutics.
January 30, 2008
Previous Page
Page 453 of 623
Next Page